Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesmary Modugno

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
JAMA Network Open|February 24, 2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic SusceptibilityLauren M Hurwitz, Penelope M Webb, Susan J Jordan, et al.
JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.
Breast Cancer Research and Treatment|November 3, 2018
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissuesYujing J Heng, Jun Wang, Thomas U Ahearn, et al.
International Journal of Cancer|August 24, 2017
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association ConsortiumAna Babic, Holly R Harris, Allison F Vitonis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
European Journal of Epidemiology|September 22, 2020
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studiesFrancesmary Modugno, Zhuxuan Fu, Susan J Jordan, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Gynecologic Oncology|January 7, 2025
Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancerJason Ricciuti, Qian Liu, A N M Nazmul H Khan, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
JAMA Network Open|February 24, 2023
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic SusceptibilityLauren M Hurwitz, Penelope M Webb, Susan J Jordan, et al.
JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.
Breast Cancer Research and Treatment|November 3, 2018
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissuesYujing J Heng, Jun Wang, Thomas U Ahearn, et al.
International Journal of Cancer|August 24, 2017
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association ConsortiumAna Babic, Holly R Harris, Allison F Vitonis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of ProgestinsMinh Tung Phung, Alice W Lee, Anna H Wu, et al.
European Journal of Epidemiology|September 22, 2020
Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studiesFrancesmary Modugno, Zhuxuan Fu, Susan J Jordan, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Gynecologic Oncology|January 7, 2025
Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancerJason Ricciuti, Qian Liu, A N M Nazmul H Khan, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Pageof 21